论文部分内容阅读
目的调查急性脑血管病患者糖代谢异常情况,以提醒医生更加关注糖代谢状态,全面制订诊、治方案,改善预后。方法选取急性脑血管病住院患者610例,记录性别、年龄、糖尿病史,测随机血糖、空腹血糖,对未确诊糖尿病患者进行口服葡萄糖耐量试验(OGTT)检测空腹和餐后2h血糖,以判断糖代谢情况。结果脑血管病住院患者中发现糖代谢异常409例(67.1%),其中糖尿病203例(33.4%),糖调节受损206例(33.7%),正常糖耐量201例(32.9%),若不进行OGTT试验仅靠空腹血糖,则有58.1%糖代谢异常患者和15.8%糖尿病患者被漏诊。结论急性脑血管病患者大多合并糖代谢异常,通过OGTT试验可以及时准确地发现这些合并糖代谢异常患者,有利于我们下一步制订更合理的诊治方案。
Objective To investigate the abnormal glucose metabolism in patients with acute cerebrovascular disease so as to remind the doctors to pay more attention to the state of glucose metabolism and make a comprehensive diagnosis and treatment plan to improve the prognosis. Methods A total of 610 hospitalized patients with acute cerebrovascular disease were enrolled in this study. Sex, age, history of diabetes mellitus, random blood glucose and fasting blood glucose were recorded. The oral glucose tolerance test (OGTT) was used to detect fasting and postprandial 2h blood glucose in patients with undiagnosed diabetes. Metabolic conditions. Results Of 409 patients (67.1%) with abnormal glucose metabolism, 203 (33.4%) had diabetes, 206 (33.7%) had impaired glucose regulation and 201 (32.9%) had normal glucose tolerance. 58% of patients with abnormal glucose metabolism and 15.8% of patients with diabetes were missed by OGTT test on fasting blood glucose alone. Conclusion Most patients with acute cerebrovascular disease complicated by abnormal glucose metabolism, OGTT test can be promptly and accurately found these patients with abnormal glucose metabolism, is conducive to the next step we develop a more rational diagnosis and treatment programs.